BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31494943)

  • 21. Effect of Continuous-Flow Left Ventricular Assist Device Support on Coronary Artery Endothelial Function in Ischemic and Nonischemic Cardiomyopathy.
    Symons JD; Deeter L; Deeter N; Bonn T; Cho JM; Ferrin P; McCreath L; Diakos NA; Taleb I; Alharethi R; McKellar S; Wever-Pinzon O; Navankasattusas S; Selzman CH; Fang JC; Drakos SG
    Circ Heart Fail; 2019 Aug; 12(8):e006085. PubMed ID: 31422672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.
    Vatta M; Stetson SJ; Jimenez S; Entman ML; Noon GP; Bowles NE; Towbin JA; Torre-Amione G
    J Am Coll Cardiol; 2004 Mar; 43(5):811-7. PubMed ID: 14998622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation.
    Khan T; Delgado RM; Radovancevic B; Torre-Amione G; Abrams J; Miller K; Myers T; Okerberg K; Stetson SJ; Gregoric I; Hernandez A; Frazier OH
    J Heart Lung Transplant; 2003 Feb; 22(2):137-46. PubMed ID: 12581761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone Modification Is Correlated With Reverse Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy.
    Ito E; Miyagawa S; Fukushima S; Yoshikawa Y; Saito S; Saito T; Harada A; Takeda M; Kashiyama N; Nakamura Y; Shiozaki M; Toda K; Sawa Y
    Ann Thorac Surg; 2017 Nov; 104(5):1531-1539. PubMed ID: 28760462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Ischaemic and Dilated Cardiomyopathy on Short-Term and Long-Term Survival After Ventricular Assist Device Implantation: A Single-Centre Experience.
    Ivanov B; Djordjevic I; Sabashnikov A; Sindhu D; Hink S; Eghbalzadeh K; Gerfer S; Gaisendrees C; Schlachtenberger G; Rustenbach C; Seuthe K; Regnier K; Mader N; Pfister R; Zeriouh M; Rahmanian P; Wahlers T
    Heart Lung Circ; 2022 Mar; 31(3):383-389. PubMed ID: 34598889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue.
    Roselló-Lletí E; Alonso J; Cortés R; Almenar L; Martínez-Dolz L; Sánchez-Lázaro I; Lago F; Azorín I; Juanatey JR; Portolés M; Rivera M
    J Cell Mol Med; 2012 Oct; 16(10):2471-86. PubMed ID: 22435364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies.
    Herpel E; Singer S; Flechtenmacher C; Pritsch M; Sack FU; Hagl S; Katus HA; Haass M; Otto HF; Schnabel PA
    Virchows Arch; 2005 Apr; 446(4):369-78. PubMed ID: 15806380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy.
    Castillero E; Akashi H; Pendrak K; Yerebakan H; Najjar M; Wang C; Naka Y; Mancini D; Sweeney HL; D Armiento J; Ali ZA; Schulze PC; George I
    Am J Physiol Heart Circ Physiol; 2015 Aug; 309(3):H459-70. PubMed ID: 26055788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and left ventricular histologic changes after implantable LVAD insertion.
    McCarthy PM; Nakatani S; Vargo R; Kottke-Marchant K; Harasaki H; James KB; Savage RM; Thomas JD
    Ann Thorac Surg; 1995 Mar; 59(3):609-13. PubMed ID: 7887698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in myocardial collagen content before and after left ventricular assist device application in dilated cardiomyopathy.
    Liang H; Müller J; Weng YG; Wallukat G; Fu P; Lin HS; Bartel S; Knosalla C; Pregla R; Hetzer R
    Chin Med J (Engl); 2004 Mar; 117(3):401-7. PubMed ID: 15043781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly.
    Butler CR; Jugdutt BI
    Heart Fail Rev; 2012 Sep; 17(4-5):615-33. PubMed ID: 22258830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptomic Signatures of End-Stage Human Dilated Cardiomyopathy Hearts with and without Left Ventricular Assist Device Support.
    Parikh M; Shah S; Basu R; Famulski KS; Kim D; Mullen JC; Halloran PF; Oudit GY
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of gene expression in failing myocardium following left ventricular assist device support.
    Chen Y; Park S; Li Y; Missov E; Hou M; Han X; Hall JL; Miller LW; Bache RJ
    Physiol Genomics; 2003 Aug; 14(3):251-60. PubMed ID: 12824457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.
    Rodrigue-Way A; Burkhoff D; Geesaman BJ; Golden S; Xu J; Pollman MJ; Donoghue M; Jeyaseelan R; Houser S; Breitbart RE; Marks A; Acton S
    J Heart Lung Transplant; 2005 Jan; 24(1):73-80. PubMed ID: 15653383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy.
    Altemose GT; Gritsus V; Jeevanandam V; Goldman B; Margulies KB
    J Heart Lung Transplant; 1997 Jul; 16(7):765-73. PubMed ID: 9257259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy.
    Küçüker SA; Stetson SJ; Becker KA; Akgül A; Loebe M; Lafuente JA; Noon GP; Koerner MM; Entman ML; Torre-Amione G
    J Heart Lung Transplant; 2004 Jan; 23(1):28-35. PubMed ID: 14734124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanical unloading increases caveolin expression in the failing human heart.
    Uray IP; Connelly JH; Frazier OH; Taegtmeyer H; Davies PJ
    Cardiovasc Res; 2003 Jul; 59(1):57-66. PubMed ID: 12829176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular changes after left ventricular assist device support for heart failure.
    Birks EJ
    Circ Res; 2013 Aug; 113(6):777-91. PubMed ID: 23989719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences?
    Klotz S; Burkhoff D; Garrelds IM; Boomsma F; Danser AH
    Eur Heart J; 2009 Apr; 30(7):805-12. PubMed ID: 19223317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.